UVA Health joins trial testing medications for mild-to-moderate COVID-19

UVA Health has joined a nationwide study evaluating two repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19.

Related Keywords

Virginia ,United States ,Doriana Rosen ,Patrickeh Jackson ,Alban Gaultier ,National Institutes Of Accelerating ,Uva Health ,National Center ,Drug Administration ,Department Of Neuroscience ,Translational Sciences ,Randomized Trial ,Evaluate Efficacy ,Repurposed Medications ,National Institutes ,Health Funded Accelerating ,Advancing Translational ,